Oral and Topical Sirolimus for Vascular Anomalies: A Multicentre Study and Review

• Hauptverfasser: Shira Sandbank (VerfasserIn), Vered Molho-Pessach (VerfasserIn), Adam Farkas (VerfasserIn), Aviv Barzilai (VerfasserIn), Shoshana Greenberger (VerfasserIn)
• Format: Buch
• Veröffentlicht: Medical Journals Sweden, 2019-08-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Vascular anomalies (VAs) may be associated with significant morbidity and mortality. The aim of this study was to evaluate the efficacy and safety of sirolimus (rapamycin) in the treatment of children and young adults with complicated VAs. A retrospective chart was created that included 19 patients...